Literature DB >> 33644271

Supporting data on combined transcriptomic and phosphoproteomic analysis of BMP4 signaling in human embryonic stem cells.

Angelos Papadopoulos1,2, Varvara Chalmantzi1, Marko Hyvönen3, Dimitris Stellas4, Marika Syrrou5, Theodore Fotsis6,7, Carol Murphy1,6.   

Abstract

Human embryonic stem cells exhibit great potential as a therapeutic tool in regenerative medicine due to their self-renewal and trilineage differentiation capacity. Maintaining this unique cellular state has been shown to rely primarily on the Activin A / TGFβ signaling pathway. While most conventional culture media are supplemented with TGFβ, in the current study we utilize a modified version of the commercially available mTeSR1, substituting TGFβ for Activin A in order to preserve pluripotency. (1) Cells cultured in ActA-mTesR express pluripotency factors NANOG, OCT4 and SOX2 at comparable levels with cells cultured in TGFβ-mTeSR. (2) ActA-mTeSR cultured cells retain a physiological karyotype. (3) Cells in ActA-mTeSR maintain their trilineage differentiation capacity as shown in the teratoma formation assay. This system can be used to dissect the role of Activin A, downstream effectors and signaling cascades in human embryonic stem cell responses.
© 2021 The Authors.

Entities:  

Keywords:  Activin A; Human embryonic stem cells; TGFβ; mTeSR

Year:  2021        PMID: 33644271      PMCID: PMC7893420          DOI: 10.1016/j.dib.2021.106844

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


  9 in total

1.  Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers.

Authors:  Gillian M Beattie; Ana D Lopez; Nathan Bucay; Andrew Hinton; Meri T Firpo; Charles C King; Alberto Hayek
Journal:  Stem Cells       Date:  2005-04       Impact factor: 6.277

2.  Feeder-independent culture of human embryonic stem cells.

Authors:  Tenneille E Ludwig; Veit Bergendahl; Mark E Levenstein; Junying Yu; Mitchell D Probasco; James A Thomson
Journal:  Nat Methods       Date:  2006-08       Impact factor: 28.547

3.  Efficient differentiation of functional hepatocytes from human embryonic stem cells.

Authors:  Sadhana Agarwal; Katherine L Holton; Robert Lanza
Journal:  Stem Cells       Date:  2008-02-21       Impact factor: 6.277

4.  MEK/ERK signaling contributes to the maintenance of human embryonic stem cell self-renewal.

Authors:  Jian Li; Guangwen Wang; Chengyan Wang; Yang Zhao; Hong Zhang; Zhijia Tan; Zhihua Song; Mingxiao Ding; Hongkui Deng
Journal:  Differentiation       Date:  2007-02-05       Impact factor: 3.880

5.  Generation of human induced pluripotent stem cells in defined, feeder-free conditions.

Authors:  Athena Kyrkou; Dimitris Stellas; Marika Syrrou; Apostolos Klinakis; Theodore Fotsis; Carol Murphy
Journal:  Stem Cell Res       Date:  2016-05-12       Impact factor: 2.020

6.  Combined transcriptomic and phosphoproteomic analysis of BMP4 signaling in human embryonic stem cells.

Authors:  Angelos Papadopoulos; Varvara Chalmantzi; Olga Mikhaylichenko; Marko Hyvönen; Dimitris Stellas; Aditi Kanhere; John Heath; Debbie L Cunningham; Theodore Fotsis; Carol Murphy
Journal:  Stem Cell Res       Date:  2020-12-18       Impact factor: 2.020

7.  Fibroblast growth factor regulates human neuroectoderm specification through ERK1/2-PARP-1 pathway.

Authors:  Young Dong Yoo; Cindy T Huang; Xiaoqing Zhang; Timothy M Lavaute; Su-Chun Zhang
Journal:  Stem Cells       Date:  2011-12       Impact factor: 6.277

8.  Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells.

Authors:  Pengbo Zhang; Jian Li; Zhijia Tan; Chengyan Wang; Ting Liu; Lin Chen; Jun Yong; Wei Jiang; Xiaomeng Sun; Liying Du; Mingxiao Ding; Hongkui Deng
Journal:  Blood       Date:  2007-11-27       Impact factor: 22.113

9.  Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells.

Authors:  Ludovic Vallier; Morgan Alexander; Roger A Pedersen
Journal:  J Cell Sci       Date:  2005-10-01       Impact factor: 5.285

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.